Manufacturing services provider Proto Labs (NYSE:PRLB) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 10.4% year on year to $139.3 million. Guidance for next quarter’s revenue was better than expected at $144 million at the midpoint, 0.7% above analysts’ estimates. Its non-GAAP profit of $0.54 per share was 37.8% above analysts’ consensus estimates.
Is now the time to buy PRLB? Find out in our full research report (it’s free for active Edge members).
Proto Labs (PRLB) Q1 CY2026 Highlights:
- Revenue: $139.3 million vs analyst estimates of $135.3 million (10.4% year-on-year growth, 3% beat)
- Adjusted EPS: $0.54 vs analyst estimates of $0.39 (37.8% beat)
- Adjusted EBITDA: $22.78 million vs analyst estimates of $19.06 million (16.3% margin, 19.5% beat)
- Revenue Guidance for Q2 CY2026 is $144 million at the midpoint, roughly in line with what analysts were expecting
- Adjusted EPS guidance for Q2 CY2026 is $0.54 at the midpoint, above analyst estimates of $0.47
- Operating Margin: 7.1%, up from 3.6% in the same quarter last year
- Market Capitalization: $1.55 billion
StockStory’s Take
Proto Labs’ first quarter results showed robust year-on-year growth, but the market reacted negatively, likely reflecting concerns about macro uncertainty and the sustainability of recent gains. Management attributed the performance to strong engagement with larger strategic customers, especially in aerospace and defense, as well as operational improvements in North America and early recovery signs in Europe. CEO Suresh Krishna specifically highlighted the 20% increase in revenue per customer and double-digit U.S. sales growth as evidence of deeper relationships with enterprise clients.
Looking ahead, Proto Labs’ guidance reflects ongoing investment in innovation, production capabilities, and operational efficiency, with management emphasizing the importance of scaling up for long-term growth. CEO Suresh Krishna stated that the company remains committed to expanding its digital manufacturing model, particularly through increased production work for strategic customers and enhancements in its global operations. CFO Dan Schumacher noted that planned increases in R&D and sales resources will support these strategic pillars, though macroeconomic uncertainty remains a consideration.
Key Insights from Management’s Remarks
Management credited the quarter’s performance to growth in strategic end markets, quality improvements, and operational changes, while noting early success in its European reset.
- Strategic customer focus: Proto Labs saw a 20% year-over-year increase in revenue per customer, with the company attributing this to deeper relationships and larger orders from enterprise clients, particularly in aerospace, defense, and robotics. Management noted that these sectors value Proto Labs’ ability to deliver speed, precision, and reliability, which are critical in high-innovation environments.
- CNC machining momentum: Exceptional demand in CNC machining, especially in the U.S., drove over 20% year-over-year growth for this service. CEO Suresh Krishna identified continued strength in aerospace, defense, and industrial robotics as primary contributors, making CNC machining a central driver of overall revenue growth.
- Injection molding progress: The injection molding business posted its strongest sequential performance in two years, benefiting from targeted quality investments and an increasing share of production (rather than prototyping) jobs for large strategic customers. Management emphasized that Proto Labs’ ability to handle both quick-turn and scheduled orders is a competitive advantage.
- Operational reset in Europe: The company executed targeted cost reductions and aligned its European operations around core industries, leading to an 11% sequential revenue increase in the region. Management described these as early but encouraging results from its strategy shift.
- Leadership and process improvements: With the hiring of Jonathan Blaisdell to lead business excellence systems, Proto Labs is embedding lean management practices and focusing on continuous improvement, quality, and productivity. This is expected to drive operational scale and efficiency across global operations.
Drivers of Future Performance
Management expects that continued growth from strategic customers, investments in innovation, and operational discipline will shape performance in the coming quarters.
- Expansion of production capabilities: Management is prioritizing the shift from prototyping to production work, particularly in injection molding and 3D printing. This transition is expected to lead to more recurring, higher-value orders from enterprise customers, with an emphasis on supporting customers throughout the product life cycle.
- Ongoing investment in innovation and infrastructure: Proto Labs plans to increase R&D and capital investments in software development, digital manufacturing technologies, and capacity expansion (especially for CNC machining and metal 3D printers). CFO Dan Schumacher highlighted that these investments are aimed at both top-line growth and improved process efficiency.
- Europe recovery and macro risks: The early success of the strategic reset in Europe will be monitored for continued improvement, but management remains cautious about macroeconomic uncertainty. This conservatism is reflected in full-year guidance, which assumes normal seasonality and potential volatility in demand, especially outside the U.S.
Catalysts in Upcoming Quarters
Looking forward, our analysts will be watching (1) the ability of Proto Labs to sustain growth with strategic customers, especially in aerospace and defense, (2) the continued recovery and margin improvement in European operations following the recent reset, and (3) the impact of increased R&D and capacity investments on both innovation and operational efficiency. Successful execution in these areas will be key to validating management’s long-term strategy.
Proto Labs currently trades at $63.61, down from $64.81 just before the earnings. In the wake of this quarter, is it a buy or sell? Find out in our full research report (it’s free).
Now Could Be The Perfect Time To Invest In These Stocks
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it's flagging for this month - FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.